A Data Collection Protocol to Evaluate the Real World Usage of the Orthofix AccelStim Device to Treat Fresh Metatarsal Fractures

Running, not enrolling

Conditions studied: Metatarsal Fracture

In brief

This study examines the effect of using the AccelStim bone growth stimulator on subjects undergoing treatment for fresh metatarsal fractures.

Key facts

Study ID

NCT07286357

Run by

Orthofix Inc.

People needed

100

Starts

2025-05-30

Expected to finish

2026-06-30

Last updated by the study team

2025-12-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Fresh metatarsal fracture patient that has been prescribed an Orthofix AccelStim device
• Patient is 18 years or older at the time of treatment

You may not qualify if…

• Patient is a prisoner

Where it is running

• Northwestern — Evanston, Illinois, United States
• Endeavor Health — Mount Prospect, Illinois, United States
• Precision Orthopedics — Laurel, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.